Neurogen Corporation (Branford, CT)...
Neurogen Corporation (Branford, CT) has released preliminary comes from a Phase 2A inquiry of NGD 91-3, a remedy candidate being evaluated for the treatment of generalized anxiety disorder. The exposes received one of two dosages of the studious mood drug, Xanax (alprazolam, Pharmacia & Upjohn Peapack, NJ) or a placebo,
|